SCHEMBL6119702

SCHEMBL6119702

CC(C)(C)N1CC[C@@](NC(=O)O)(S(=O)(=O)c2cc(Br)cnc2N)C1

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 4/20 0.44
KDM4E B2RXH2 3/20 0.44
GAA P10253 1/20 0.41
NPC1 O15118 1/20 0.41
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
MAPT P10636 3/20 0.39
LMNA P02545 2/20 0.39
GFER P55789 1/20 0.39
ALDH1A1 P00352 3/20 0.38
RAB9A P51151 1/20 0.38
PLA2G1B P04054 1/20 0.36
ATG4B Q9Y4P1 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL856412 0.74 HSD17B10 (0.54) HSD17B10KDM4EGAANPC1MEN1
SCHEMBL862274 0.67 HSD17B10 (0.52) HSD17B10KDM4EGAANPC1MEN1
SCHEMBL6118943 0.67 HSD17B10 (0.66) HSD17B10KDM4EGAANPC1MEN1
SCHEMBL856697 0.66 HSD17B10 (0.50) HSD17B10KDM4EGAANPC1MEN1
SCHEMBL6120283 0.65
SCHEMBL6125985 0.63 NPC1 (0.39) HSD17B10KDM4EGAANPC1MEN1
SCHEMBL6119304 0.63 HSD17B10 (0.71) HSD17B10KDM4EGAANPC1MEN1
SCHEMBL6119699 0.63 HSD17B10 (0.48) HSD17B10KDM4EGAANPC1MEN1
SCHEMBL6119695 0.63 HSD17B10 (0.48) HSD17B10KDM4EGAANPC1MEN1
SCHEMBL858207 0.63 HSD17B10 (0.57) HSD17B10KDM4EGAANPC1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640366-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE Exelixis, Inc. (US) 2013-09-25 EP disclosed
WO-2012068096-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2012-05-24 WO disclosed